Standard BioTools Inc.
LABStandard BioTools is a life science tools company that provides essential, standardized solutions for biomedical research and drug development.
Table of contents
Earnings
Next report
Aug 5, 2026 (In 1 week)Competitors
By market cap
By revenue growth
Profile
Standard BioTools is a life science tools company that provides essential, standardized solutions for biomedical research and drug development. The company offers a diverse portfolio of instrumentation, consumables, and services focused on high-dimensional proteomics and genomics. Its core value proposition lies in enabling researchers to extract deep biological insights from complex samples through advanced mass cytometry and microfluidics technologies.
The company is a specialized provider of high-parameter protein analysis and microfluidic genomic tools, positioning itself as an alternative to traditional flow cytometry and bulk genomic methods.
Questions, answered.
- What is Standard BioTools Inc.'s market cap?
- Standard BioTools Inc. (LAB) has a market capitalization of $303.2M and trades on NASDAQ.
- Who are Standard BioTools Inc.'s competitors?
- Standard BioTools Inc.'s key competitors include 10x Genomics, Bio-Rad Laboratories, Thermo Fisher Scientific, and others. These companies compete in similar markets and product categories.
- Who does Standard BioTools Inc. partner with?
- Standard BioTools Inc.'s notable partners include Illumina, California Institute of Technology, Harvard University, and others.
- Where is Standard BioTools Inc. headquartered?
- Standard BioTools Inc. is headquartered in United States of America and employs approximately 539 people. It has been publicly traded since 2011.